Exelixis Clinical Site #11

Omaha, Nebraska 68130

0 studies enrolling now · 2 studies all time

What they study most

Cervical Cancer, Differentiated Thyroid Cancer, Endometrial Cancer, Epithelial Ovarian Cancer, Esophageal SCC, Hormone Receptor-positive Breast Cancer, Metastatic Castration-resistant Prostate Cancer, Non Small Cell Lung Cancer, Pancreatic Cancer, SCCHN, Tissue Factor-Expressing Solid Tumors, Triple Negative Breast Cancer

Studies at this site

• A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted Therapy — Running, not enrolling
• Study of XB002 in Subjects With Solid Tumors (JEWEL-101) — Completed